Multimorbidity Management: A scoping review of comprehensive interventions for multimorbidity outcomes

Kagiso P Seakamela, Reneilwe G Mashaba, Cairo B Ntimana, Chodziwadziwa W Kabudula, Tholene Sodi
doi: https://doi.org/10.1101/2025.01.29.25321304

Abstract

Background Multimorbidity, defined as the co-occurrence of two or more chronic conditions in an individual, has emerged as a worldwide public health concern contributing to mortality and morbidity. With a prevalence estimated at 37% globally, this complex health phenomenon is increasingly affecting populations as they age. Despite the growing burden of multimorbidity, the development and implementation of interventions published by scholars are still in their early stages with significant variability in strategies and outcomes.

Objectives The review aims to synthesize interventions designed to manage and mitigate multimorbidity and explore a range of approaches, including pharmacological treatments, lifestyle modifications, care coordination models, and technological innovations.

Methods The scoping review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist. It included about 1,227,906 individuals with multimorbidity, with 199,413 being male (16.2%) and 1,028,493 (83.8%) female participants. Multimorbidity interventions were defined as strategies or programs designed to manage and improve the health and quality of life of individuals with multiple chronic conditions.

Results The final analysis included 101 articles from 3119 published between 2012 and 2024. Themes on the need for lifestyle and behavioural interventions, patient empowerment and engagement, multimorbidity management, health integration, pharmacotherapy optimization, community and policy interventions, healthcare system improvements, technology and digital health, as well as research and evidence-based practice interventions, emerged.

Conclusion The reviewed literature emphasizes the necessity of multidisciplinary approaches to effectively combat the escalating pandemic of multimorbidity.

Introduction

Multimorbidity, defined as the co-occurrence of two or more chronic conditions in an individual, has emerged as a worldwide public health concern contributing to mortality and morbidity [1–3]. This complex health phenomenon is increasingly becoming prevalent (37.2% globally) affecting populations especially as they age [4,5]. Multimorbidity complicates clinical management and exacerbates health outcomes, leading to reduced quality of life, and increased health utilization and costs [6–8]. Even though the prevalence of multimorbidity is projected to remain on an upward trend, policy and research remain focused on single diseases making it difficult to prevent multimorbidity better[9,10].

Multimorbidity has been described as a ‘defining challenge’ for health systems, which are traditionally focused on single conditions[11]. This calls for effective interventions to address the multifaceted needs of patients with multimorbidity, encompassing a holistic approach that integrates medical, psychological, and social dimensions of care [12–14]. Despite the growing burden of multimorbidity, the development and implementation of interventions published by scholars are still in their early stages with significant variability in strategies and outcomes [12–14]. In addition, the application of the proposed interventions may be affected by the socioeconomic status of the respective countries.

The vast research published on multimorbidity recommends possible interventions that scientists and policymakers could adopt [6,15,16]. This review aims to synthesize interventions designed to manage and mitigate multimorbidity and explore a range of approaches, including pharmacological treatments, lifestyle modifications, care coordination models, and technological innovations.

Background on Multimorbidity Interventions

Multimorbidity interventions are defined as strategies or programs designed to manage and improve individuals’ health and quality of life with multiple chronic conditions[15]. Given the challenge of managing several chronic illnesses simultaneously, multimorbidity management has placed a greater emphasis on patient-centred interventions. Integrated care approaches, which promote collaboration across interdisciplinary teams to address patients’ medical, social, and psychological needs holistically, are among the most crucial strategies. Patient empowerment via self-management measures, such as education on medication adherence and lifestyle changes, improves results and lessens the burden of therapy. Remote monitoring and telemedicine are two examples of technology-based therapies that have demonstrated potential in improving accessibility and continuity of care, especially for underprivileged populations. To make sure that therapies meet patients’ objectives and lower the hazards of polypharmacy (such as adverse drug interactions), these interventions are supplemented by shared decision-making frameworks and systematic medication reviews [15,17,18].

Methods

This scoping review was conducted and reported following the Preferred Reporting Item for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist (see supplementary file)[19]. To ensure transparency, the authors searched multiple databases for similar scoping reviews to avoid duplication. Without such a review, the authors continued with the scoping review.

Search strategy

To reduce selection bias, three (3) authors (K.P.S., R.G.M., and C.B.N.), systematically searched for relevant studies from 1 April 2024 to 30 June 2024. About five electronic databases (PubMed, Google Scholar, Science Direct, Cochrane and Scopus) were searched for relevant evidence. The search strategy was first drafted and tested using PubMed. This was further adapted to the syntax and subject headings of all other databases searched in the study. Keywords used in the search were “Multimorbidity”, “Multiple chronic conditions”, and “Interventions”. In addition, reference lists of all eligible articles identified were searched and screened for additional relevant studies. The search strategy for PubMed has been included in the supplementary file as an example.

Inclusion and exclusion criteria

Studies were reviewed against pre-determined inclusion and exclusion criteria for eligibility. Peer-reviewed studies were included if they investigated multimorbidity interventions or proposed multimorbidity interventions in their recommendations, written in English and not reviews. Studies were excluded if they focused on single morbidity, did not have multimorbidity interventions, were not written in English and were reviewed. The present review did not have age and type of multimorbidity restrictions.

Study selection

Selection and inclusion of papers for this review involved a two-stage process: screening of abstracts and titles; and full-text reading to select eligible papers for final inclusion. Three independent reviewers (K.P.S., R.G.M., and C.B.N.) conducted the selection process through each stage of the review. After the database search, the results were exported to Zotero, a bibliographic management software, where duplicates were removed. After removing the duplicates, the reviewers applied the pre-determined inclusion and exclusion criteria and independently assessed the titles and abstracts for full-text review eligibility. Following this process, articles were selected for full-text screening. Again, the reviewers applied the inclusion and exclusion criteria and independently assessed the full-text articles. After each stage of the selection process, the reviewers compared results and reached a consensus, with a fourth reviewer and a fifth reviewer serving as a tie-break in situations where the three reviewers failed to reach an agreement.

Data extraction

Relevant data were extracted from eligible articles using a Microsoft Excel spreadsheet. These included author name, date of publication, country of study; the main objective of the study; study design and participants, sample size and gender distribution.

Results

Out of a pool of 3119 articles identified from the database, full-text articles were assessed for eligibility. About 1400 articles were excluded due to not being relevant to the present review (n = 280), lack of multimorbidity interventions (n = 868), focus on single morbidity (n = 196) and reviews (n = 56) (Figure 1). The final analysis included 101 articles from 3119 published between 2012 and 2024. The included studies comprised various research designs: 54 Randomized controlled trials (53.5%), 32 cross-sectional (32.7%) and six cohorts (5.9%). Longitudinal, qualitative and population-based studies contributed about 2.9% respectively. The sample sizes of these studies ranged from 6 to 712,822 participants. In total, 1,227,906 individuals with multimorbidity participated in these studies, with 199,413 being male (16.2%) and 1,028,493 (83.8%) female participants. Three articles did not report sample size while 12 studies reported total sample size but not gender distribution. The geographical distribution of these studies was as follows: About 27 studies were from Africa, 5 Asia, 2 Australia, 30 Europe and 15 North America. About 19 of the included studies were multinational studies. Figure 2 presents percentages of studies from each continent and percentages of individual countries within respective continents. Figure 3. Presents the distribution of interventions in the 101 studies included in the review, stratified by countries’ financial status. Furthermore, table S1 presents a summary of the included studies’ characteristics.

Figure 1:
Figure 1:

Study selection flow diagram

Figure 2:
Figure 2:

Distribution of countries and continents from which included studies were conducted. A: Shows continental distribution with Europe and Africa having the highest parentage. B and D: represent the distribution by country for Africa and Europe. C: country distribution for North America, Asia and Australia.

Figure 3:
Figure 3:

Distribution of interventions in the 101 studies included in the review, stratified by countries’ financial status. (A) Low income (B) Upper-Middle-Income (C) High-Income (D) Global. upSet plot generated using Rstudio.

View this table:
Table S1: Summary of included studies
View this table:
Table2: Summary of themes identified

Upon thematic analysis, this scoping and review identified 9 themes summarized in Table 2.

Lifestyle and Behavioural Interventions

Physical activity

Lifestyle changes were identified as a positive factor in managing multimorbidity. About eleven (11) studies indicated that physical activity and exercise programs were important among individuals with multimorbidity [22,24,30,33–35,39,41,50,57,99]. This was to be done by encouraging individuals with multimorbidity to engage in regular exercise, which may be incorporated into community programs. In addition, the provision of individual counselling, as well as access to fitness facilities and organized activities, were noted to have potential benefits for individuals with multimorbidity. Designing structured exercise programs, tailored for individual capabilities and extend of multimorbidity. Some studies suggested cost-effective exercise programs consisting of aerobics [24,57] and low-volume cycling to improve body composition [30]. Participating in brisk walking for more than 175 minutes per week also had a positive impact on inducing weight loss [34].

Smoking Cessation, alcohol reduction and Weight Management

Lifestyle interventions such as quitting smoking dietary advice reducing alcohol consumption we found in several studies to have a positive impact on the management of multimorbidity [22,33,41,50,61,70,79,88]. Interventions such as offering support and resources for quitting smoking, implementing weight management programs that include dietary advice and physical activity, programs to reduce alcohol consumption and community-based initiatives to promote overall wellness were suggested. One study reported that reducing caloric intake and increasing physical activity to induce weight loss to average >7% at year 1 and maintaining this over time could lessen the burden of multimorbidity [35].

Patient Empowerment and Engagement

Self-Management Skills Training

Several studies reported the importance of teaching patients skills to manage individual chronic health conditions independently and offering programs that build confidence and competence in self-care and self-monitoring to adjust lifestyle habits and make healthy lifestyle choices [24,32,39,46,51,53,55,56,60,62,95]. Mbokazi et al., further highlighted the need to incorporate and recognize cultural norms in interventions need such as the role that Ubuntu plays for people living with multimorbidity in South Africa and consider how existing social networks can be strengthened to enhance self-management capacity [62]. This is especially true in a changing healthcare landscape where patients are expected to take more responsibility for their health. Tomita et al., further recommend a restructure of the social welfare framework and establish culturally sensitive healthcare systems capable of managing multimorbidity amidst the unprecedented urbanization occurring in Tanzania [106]. Information material for patients to increase self-management abilities and reduce language barriers and difficulties of comprehension was found useful in achieving this intervention [45,46]. In addition, addressing key non-disease-specific self-management challenges and themes (mastering emotions, managing treatments, and communication within health care) [51]. Developing accessible educational resources for patients on various health topics. Providing printed and digital materials to support patient learning. Organizing group sessions where patients can learn and practice self-management skills. Facilitating peer support and sharing of experiences.

Assisting patients with goal setting and prioritization, peer support, health services navigation

Helping patients set realistic and achievable health goals and prioritizing interventions based on what is important to the patient [39,41,101]. Goal setting and prioritization based on patient preferences should include interventions to support patient self-management used in the groups including self-management, fatigue and energy management, managing stress, anxiety, and maintaining mental health and well-being, keeping physically active, healthy eating, managing medications, effective communication strategies, and goal setting [39]. In addition, facilitating peer support groups where patients can share experiences and advice was found to be necessary for patient empowerment and engagement [39]. Furthermore, Garvey et al. pointed out the importance of helping patients with multimorbidity to navigate the healthcare system and provide them with guidance on how to access services and coordinated care by employing health navigators services [31]. Health navigators are professionals who can assist individuals with multimorbidity to overcome factors that may prevent them from accessing healthcare (e.g. financial, transportation, knowledge-based skills, and complex medical systems) to help them manage and cope with disease-related symptoms and health problems [31].

Multimorbidity Management

Multidisciplinary and multi-sectoral collaboration and support in healthcare systems

Establishing integrated care pathways that connect various healthcare providers and services as well as engaging social services, community organizations, and policymakers in comprehensive care plans [21,25,49,54]. This ensures continuity of care across different settings and specialities and facilitates teamwork among healthcare professionals from various disciplines thus encouraging shared decision-making and team-based care [21,25,49,54]. Multi-sectoral interventions are required beyond the healthcare sector to reduce the impact of NCDs on health systems and broader societal development [49].

Patient-centred Care

Focusing on the individual needs and preferences of patients, implementing personalized care plans that address multiple health conditions, restructuring healthcare delivery models to be more efficient and patient-centred and implementing care teams and case management approaches [43,77,86,105,116]. The current models of health care delivery need to be re-examined and patient-centred models of integration evaluated including bidirectional screening of commonly co-morbid conditions in routine clinical practice [77]. A cost-effective and patient-centred approach to the treatment and care of multiple comorbidities is required in treating multimorbidity [43,105].

Preventive Strategies for chronic disease and modifiable risk factor

Several studies highlighted the need for prevention and early intervention for chronic diseases including regular monitoring and management to prevent complications [25,84,98,99,118]. Prevention initiatives tailored to non-communicable diseases with a special target to diseases and health conditions that have the most detrimental effects on health-related quality of life [98]. Affordable, broad-scale interventions, such as promoting healthy lifestyles, preventing and managing chronic conditions, and subsequently, multimorbidity [99]. In addition, other studies reported the need to increase activities and expand measures to reduce the modifiable risk factors that are driving multi-morbidity prevalence [21,25,35,37,69,91]. Concerted efforts to develop strategies for the planning, prevention and management of modifiable risk factors that drive the high prevalence of multimorbidity including monitoring of cardiometabolic risk factors (lipids, HbA1c, blood pressure) [35,69].

Mental Health Integration

Integrating mental health screening and treatment along with collaborative care for mental health and physical conditions

Implementing models of care that integrate mental health services with primary care using team-based approaches to manage co-existing mental and physical health conditions [29,32,39,41,72,75,81,99,112]. This is because mental health conditions tend to affect the treatment outcomes of patients with multimorbidity. This can be done by providing access to therapies like cognitive-behavioural therapy (CBT) and encouraging patients to track their mental health symptoms and triggers. Routine screening for depression and anxiety in patients with multimorbidity and offering treatment options that address both mental and physical health needs. Oh et al., reported the need for interventions aimed at minimizing distress, which has been associated with a lower adherence to treatment, leading to worsening of disease severity and outcomes. Raising awareness on distress and related mental health problems and promoting utilization of mental health care among people with multimorbidity [75].

Pharmacotherapy Optimization

Medication Reviews

Several studies highlighted the importance of regular comprehensive reviews of patient medications to ensure appropriateness, effectiveness, and safety with the aims of identifying and discontinuing potentially inappropriate medications to reduce significant polypharmacy by de-prescription of unnecessary medicines [44,46,53,54,65,66,107]. Medication reviews also increase expert knowledge and feasibility of instruments for systematic medication reviews, and implementation of an integrated healthcare model for multimorbid patients based on improving communication between primary care and hospital professionals [44,46,53,54,65,66,107]. Additionally, the studies highlighted the need to perform a brown bag medication review and record any problems identified and, assess and record patients’ priorities for treatment [44,46,53,54,65,66,107].

Use of software-based tools and clinical decision support systems

Utilizing tools like STOPP (Screening Tool for Older People’s Prescriptions) and START (Screening Tool to Alert to the Right Treatment) criteria to guide prescribing practices and implementing clinical decision support systems that incorporate these criteria [20,44,48,93,94]. This assists in reducing inappropriate prescribing through, systematic medication and predicting adverse medication effects, advising safe and appropriate therapy using and monitoring clinically relevant interactions and dosing[20]. Factors such as Structured History taking of Medication use (SHiM) and collection of patient data including medical conditions, laboratory data and clinical parameters, digitalize screening of pharmacotherapy through a Clinical Decision Support System (CDSS) should be incorporated to detect potential overuse, underuse, and misuse of drugs [44]. The use of software-based tools and clinical decision support systems assist in improvements in medication reconciliation across healthcare settings to avoid unintentional re-prescription of medication [20,44,48,93,94].

Shared Decision-Making with Patients

Involving patients in discussions about their medications, considering their preferences and experiences[20,47,78,94]. Educating patients about the benefits and risks of their treatments.

Community and Policy Interventions

Policy interventions for physical activity infrastructure and community engagement programs

About seven (7) articles reported the need to develop public health policies that seek to promote the construction of recreational facilities to promote and facilitate physical activity [23,25,31,39,62,87,117]. In addition, the importance of community engagement events and programs that promote health and well-being, and foster social connections and support networks were highlighted as probable interventions [23,25,31,39,62,87,117]. Furthermore, the studies highlighted the need to address social determinants of health through community-based approaches [23,25,31,39,62,87,117].

Financial Assistance

Factors such as lack of financial means were also found to play a role in the management or lack thereof of multimorbidity. As an intervention, some studies therefore recommended the need to offer financial support for individuals with multimorbidity to eliminate the financial barrier they face in accessing health services [23,80,110].

Healthcare System Improvements

Enhancing Communication between primary care and hospitals

The present review found that there remained a lack of communication between healthcare providers in hospitals, which needs to be improved through the incorporation of health information technology and integrated care systems that connect primary, secondary, and tertiary care to facilitate communication between health professionals and enhance coordination between various levels of care is necessary [39,51,53].

Strengthening Capacity and Training for Healthcare Workers

Providing ongoing education and training for healthcare workers for multimorbidity management. Offering specialized training for healthcare providers on managing multimorbidity. Conducting workshops and seminars to enhance clinical skills [30,36,45,63,117].

Technology and digital health

Some studies revealed the need for technology and digital health in the management of multimorbidity [25,112,115]. This includes internet-based self-management programs, telehealth and telephone nursing support, electronic registries and tracking systems and the use of mobile apps for patient engagement [25,112,115]. Some studies promoted the use of technology and digital health to offer patients online platforms to learn about and manage multimorbidity [25,112,115]. This further provides healthcare workers with the opportunity to track and monitor health metrics, remote consultations and follow-ups, and monitor health outcomes. Creating mobile applications that support patient engagement and self-management [25,112,115].

Research and Evidence-Based Practice

Conducting long-term research to investigate underlying mechanisms and risk factors to understand the causes and risk factors for multimorbidity, exploring the interactions between different health conditions, tracking the progression and impact of multimorbidity and analyzing data to inform future healthcare practices [6,42,61,63,69,74,77,80,82,85,88,100,102,103,109]. Creating and testing new approaches to managing multimorbidity. Focusing on interventions that are patient-centred and effective [6,42,61,63,69,74,77,80,82,85,88,100,102,103,109]. Assessing the effectiveness of integrated care models. Using evidence to refine and improve care delivery systems [6,42,61,63,69,74,77,80,82,85,88,100,102,103,109].

Discussion

This review aimed to synthesize interventions designed to manage and mitigate multimorbidity and explore a range of approaches, including pharmacological treatments, lifestyle modifications, care coordination models, and technological innovations. The results of the current review revealed the need for lifestyle and behavioural interventions, patient empowerment and engagement, multimorbidity management, health integration, pharmacotherapy optimization, community and policy interventions, healthcare system improvements, technology and digital health, as well as research and evidence-based practice interventions. The reviewed literature emphasizes the necessity of multidisciplinary approaches to effectively combat the escalating pandemic of multimorbidity.

The reviewed studies suggest the need for lifestyle changes that include physical activity targeting weight loss as well as reducing alcohol consumption and smoking cessation as a mechanism that can improve multimorbidity management [17,19,25,28–30,34,36,46,53,57,66,75,84,96]. Smoking, alcohol consumption and physical inactivity are well-known risk factors for multimorbidity [119,120]. Since the majority of people suffering from multimorbidity are older, the literature recommends exercises that include aerobics and brisk walking which have been reported to improve general body weight [51,121]. A study by Zou and colleagues reported smoking behaviour, age of initiation, frequency of daily smoking and passive smoking to increase the risk of multimorbidity [122]. The increased risk of multimorbidity among smokers can be explained by the reported implication of smoking towards the individual impact of smoking on cardiovascular risk including diabetes, heart disease and stroke morbidities [122–124].

It is worth noting that self-care plays a crucial role in the successful management of chronic diseases and multimorbidity. In the reviewed literature patient empowerment and engagement came out as one of the recommendations to combat the burden of multimorbidity [19,27,34,36,41,47,49,51,52,56,58,92,98]. Financial and educational status have been associated with the increased risk of multimorbidity, therefore the two factors will impact how patients suffering from multimorbidity manage their conditions [6,125,126]. Interventions aimed at overcoming the financial and educational barriers emerged from the reviewed literature where it was suggested that patients should be provided with culturally sensitive materials, educated on chronic conditions and management, patient-centred goal setting, and peer support [19,18,27,34,41,47,49,51,52,56,58,76,92,108]. Empowering patients with these skills and having peers who advocate for effective self-care will bring confidence in patients with multimorbidity, which will help them navigate the healthcare system. Also, the shared decision-making with patients about their medication, preferences and experiences could be beneficial to the healthcare system in pursuit of successful multimorbidity management [20,47,78,94]. A scoping review by Marzban and colleagues managed to show a positive impact of patient engagement on treatment adherence and self-care [127].

Multimorbidity is a complex phenomenon that requires more than the traditional approaches to healthcare provision. The findings of this review suggest a multidisciplinary and multi-sectoral collaboration and support in healthcare systems [21,25,49,54]. The involvement of various healthcare providers in patient care would be beneficial to the fragmented healthcare systems in that there would be shared patient-care decision-making. There’s also a need for patient-centred care which serves the needs of individuals as patients are different. Studies have shown the beneficial impact of multidisciplinary approaches in patient care [128,129]. Multimorbidity has been associated with mental health conditions, this can be due to observed reduction in quality of life, medication side effects and fear of death [130–132]. Multidisciplinary approaches aimed at integrating mental health into primary healthcare and facilitating pharmacotherapy optimization are necessary in caring for patients with multimorbidity according to the reviewed literature [24,27,34,36,39,41,49,50,61,62,68,71,77,96,110,104].

Reviewed literature suggests that medication reviews and the use of software-based tools and clinical decision support systems can achieve pharmacotherapy optimization [15,39,41,44,49,50,61,62,89,91,104]. Patients with multimorbidity are often subjected to polypharmacy, reviewed literature recommends medication reviews to reduce significant polypharmacy by de-prescription of unnecessary medicines. Models such as STOPP, START, SHiM and CDSS are reported to be promising interventions to reduce polypharmacy and monitoring prescriptions. Software-based tools and clinical decision support systems assist in improvements in medication reconciliation across healthcare settings to avoid unintentional re-prescription of medication [20,44,48,93,94].

The results of this review revealed the need for improvement in the healthcare system. This includes continuity of care and better communication between healthcare providers (primary healthcare providers and hospitals). Suggested interventions include the development of a digital system which will link the information of the patient across all platforms of care, internet-based self-management programs, telehealth and telephone nursing support, electronic registries and tracking systems and the use of mobile apps for patient engagement [25,112,115]. Implementing these systems would reduce the need to go to the healthcare facilities and queue for hours in some areas, and the cost of travelling to and from the health facilities, which are hindrances to people in extreme poverty from accessing health care. Also, the digital systems give an overview of and perspective and longitudinal health of a patient which has been reported to improve patient care [133–137].

Strengthening capacity and training for healthcare workers through ongoing specialized training on managing multimorbidity is also recommended by the reviewed literature, which is essential in medication regimens and the application of technology. The continued training will capacitate the healthcare providers and health systems to manage multimorbidity which is complex and needs different approaches than the ones already being used [138–140]. There is a need for long-term research to investigate underlying mechanisms and risk factors to understand the causes and risk factors of multimorbidity. Therefore, the data generated from long-term investigations can be used to create evidence-based policies that effectively serve the communities and reduce the burden of multimorbidity and chronic conditions [85,88,100,102,103,109].

Conclusion

This review underscores the growing complexity of multimorbidity and the urgent need for innovative and comprehensive approaches to manage it effectively. The synthesis of current interventions highlights the critical importance of lifestyle and behavioural changes, patient empowerment, and a more integrated healthcare system. By applying the recommended multidisciplinary care models, optimizing pharmacotherapy, and leveraging technology, we can improve the quality of life for those living with multiple chronic conditions. Moreover, the review revealed the value of personalized care, where the unique needs and circumstances of individuals are acknowledged and addressed.

Promoting self-care and treatment adherence requires patient empowerment via education and collaborative decision-making, particularly in regions with limited resources and educational opportunities. As we move forward, the advancement of digital health technologies and the inclusion of mental health services in primary care will be essential in tackling the complex issues surrounding multimorbidity in the future. Effective multimorbidity management requires a team effort involving legislators, patients, communities, and healthcare practitioners to build a more adaptable and durable healthcare system.

Author Contributions

Conceptualization, K.P.S., and G.R.M.; Methodology K.P.S., and G.R.M.; Investigation, Methodology K.P.S., G.R.M., and C.B.N.; Validation, K.P.S., G.R.M., and C.B.N; Writing—original draft, K.P.S., G.R.M., and C.B.N; Writing—review and editing, K.P.S., G.R.M., C.B.N., CWK, TS. All authors have read and agreed to the published version of the manuscript.

Funding

The work reported herein was made possible through funding by the South African Medical Research Council (SAMRC) through its South African Population Research Infrastructure Network under the Nodal PhD Fellowship Programme; from funding received from the Department of Science, Technology and Innovation. The content hereof is the sole responsibility of the authors and does not necessarily represent the official views of the SAMRC.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data produced in the present work are contained in the manuscript.

Data Availability

All data produced in the present work are contained in the manuscript

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgements

The authors thank the DIMAMO PHRC for the support of the research.

References

  1. 1.↵
    Forslund T, Carlsson AC, Ljunggren G, Ärnlöv J, Wachtler C. Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study. Family practice. 2021;38(2):132–9.
    OpenUrlPubMed
  2. 2.
    Kadambi S, Abdallah M, Loh KP. Multimorbidity, function, and cognition in aging. Clinics in geriatric medicine. 2020;36(4):569–84.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Willadsen TG, Siersma V, Nicolaisdóttir DR, Køster-Rasmussen R, Reventlow S, Rozing M. The effect of disease onset chronology on mortality among patients with multimorbidity: A Danish nationwide register study. Journal of Multimorbidity and Comorbidity. 2022 Nov 1;12:26335565221122025.
    OpenUrl
  4. 4.↵
    Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023 Mar;57:101860.
    OpenUrlPubMed
  5. 5.↵
    Gyasi RM, Phillips DR. Aging and the rising burden of noncommunicable diseases in sub-Saharan Africa and other low-and middle-income countries: A call for holistic action. The Gerontologist. 2020;60(5):806–11.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nature Reviews Disease Primers. 2022;8(1):48.
    OpenUrlPubMed
  7. 7.
    Tran PB, Kazibwe J, Nikolaidis GF, Linnosmaa I, Rijken M, Van Olmen J. Costs of multimorbidity: a systematic review and meta-analyses. BMC Med. 2022 Dec;20(1):234.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Van Wilder L, Devleesschauwer B, Clays E, De Buyser S, Van Der Heyden J, Charafeddine R, et al. The impact of multimorbidity patterns on health-related quality of life in the general population: results of the Belgian Health Interview Survey. Qual Life Res. 2022 Feb;31(2):551–65.
    OpenUrlPubMed
  9. 9.↵
    Head A, Fleming K, Kypridemos C, Pearson-Stuttard J, O’Flaherty M. Multimorbidity: the case for prevention. J Epidemiol Community Health. 2021 Mar 1;75(3):242–4.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Kingston A, Robinson L, Booth H, Knapp M, Jagger C, for the MODEM project. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model. Age and Ageing. 2018 May 1;47(3):374–80.
    OpenUrlPubMed
  11. 11.↵
    Pearson-Stuttard J, Ezzati M, Gregg EW. Multimorbidity—a defining challenge for health systems. The Lancet Public Health. 2019 Dec 1;4(12):e599–600.
    OpenUrl
  12. 12.↵
    Endalamaw A, Zewdie A, Wolka E, Assefa Y. Care models for Individuals with Chronic Multimorbidity: Elements, Impact, Implementation Challenges and Facilitators [Internet]. 2024 [cited 2024 Jul 8]. Available from: https://www.researchsquare.com/article/rs-4511114/v1
  13. 13.
    Salisbury C, Man MS, Bower P, Guthrie B, Chaplin K, Gaunt DM, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach. Lancet. 2018 Jul 7;392(10141):41–50.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Simpson G, Stuart B, Hijryana M, Akyea RK, Stokes J, Gibson J, et al. Eliciting and prioritising determinants of improved care in multimorbidity: A modified online Delphi study. J Multimorb Comorb. 2023 Sep 5;13:26335565231194552.
    OpenUrlPubMed
  15. 15.↵
    Smith SM, Wallace E, Clyne B, Boland F, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community setting: a systematic review. Syst Rev. 2021 Dec;10(1):271.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Zhou Y, Dai X, Ni Y, Zeng Q, Cheng Y, Carrillo-Larco RM, et al. Interventions and management on multimorbidity: An overview of systematic reviews. Ageing research reviews. 2023;87:101901.
    OpenUrlPubMed
  17. 17.↵
    Salisbury C, Man MS, Bower P, Guthrie B, Chaplin K, Gaunt DM, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach. Lancet. 2018 Jul 7;392(10141):41–50.
    OpenUrlCrossRefPubMed
  18. 18.↵
    Lammila-Escalera E, Greenfield G, Aldakhil R, Zaman H, Neves AL, Majeed A, et al. Structured medication reviews for adults with multimorbidity and polypharmacy in primary care: a systematic review protocol. BMJ open. 2024;14(5):e082825.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 2;169(7):467–73.
    OpenUrlCrossRefPubMed
  20. 20.↵
    Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M’Rabet-Bensalah K, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019 Jun 3;9(6):e026769.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Afshar S, Roderick PJ, Kowal P, Dimitrov BD, Hill AG. Multimorbidity and the inequalities of global ageing: a cross-sectional study of 28 countries using the World Health Surveys. BMC Public Health. 2015 Dec;15(1):776.
    OpenUrlCrossRefPubMed
  22. 22.↵
    Andersen H, Kankaanranta H, Tuomisto L, Piirila P, Sovijarivi A, Langhammer A, et al. Multimorbidity in Finnish and Swedish speaking Finns - association with daily habits and socioeconomic status - A Nordic EpiLung study. European respiratory journal [Internet]. 2020;56. Available from: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02229028/full
  23. 23.↵
    Awuviry-Newton K, Amponsah M, Amoah D, Dintrans PV, Afram AA, Byles J, et al. Physical activity and functional disability among older adults in Ghana: The moderating role of multi-morbidity. PLOS Global Public Health. 2023;3(3):e0001014.
    OpenUrl
  24. 24.↵
    Barker K, Holland A, Lee A, Ritchie K, Boote C, Lowe S, et al. A rehabilitation programme for people with multimorbidity versus usual care: a pilot randomized controlled trial. Journal of comorbidity. 2018;8(1):2235042X18783918.
    OpenUrlPubMed
  25. 25.↵
    Berntsen GKR, Dalbakk M, Hurley JS, Bergmo T, Solbakken B, Spansvoll L, et al. Person-centred, integrated and pro-active care for multi-morbid elderly with advanced care needs: a propensity score-matched controlled trial. BMC Health Serv Res. 2019 Oct 3;19(1):682.
    OpenUrlCrossRefPubMed
  26. 26.
    Bleijenberg N, Ten Dam VH, Steunenberg B, Drubbel I, Numans ME, De Wit NJ, et al. Exploring the expectations, needs and experiences of general practitioners and nurses towards a proactive and structured care programme for frail older patients: a mixed-methods study. J Adv Nurs. 2013 Oct;69(10):2262–73.
    OpenUrlPubMed
  27. 27.↵
    Blum MR, Sallevelt BTGM, Spinewine A, O’Mahony D, Moutzouri E, Feller M, et al. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ. 2021 Jul 13;374:n1585.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Bowling CB, Sloane R, Pieper C, Luciano A, Davis BR, Simpson LM, et al. Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults. J Am Geriatr Soc. 2020 Sep;68(9):2059–66.
    OpenUrlPubMed
  29. 29.↵
    Camacho EM, Davies LM, Hann M, Small N, Bower P, Chew-Graham C, et al. Long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity: cluster-randomised trial. Br J Psychiatry. 2018 Aug;213(2):456–63.
    OpenUrlPubMed
  30. 30.↵
    Carballeira E, Censi KC, Maseda A, López-López R, Lorenzo-López L, Millán-Calenti JC. Low-volume cycling training improves body composition and functionality in older people with multimorbidity: a randomized controlled trial. Sci Rep. 2021 Jun 28;11(1):13364.
    OpenUrlPubMed
  31. 31.↵
    Contant E, Loignon C, Bouhali T, Almirall J, Fortin M. A multidisciplinary self-management intervention among patients with multimorbidity and the impact of socioeconomic factors on results. BMC family practice. 2019;20(1):53.
    OpenUrlPubMed
  32. 32.↵
    Coventry P, Lovell K, Dickens C, Bower P, Chew-Graham C, McElvenny D, et al. Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease. BMJ. 2015 Feb 16;350:h638.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    Dzomba A, Ginsburg C, Kabudula CW, Yorlets RR, Ndagurwa P, Harawa S, et al. Epidemiology of chronic multimorbidity and temporary migration in a rural South African community in health transition: A cross-sectional population-based analysis. Frontiers in Epidemiology. 2023;3:1054108.
    OpenUrlPubMed
  34. 34.↵
    Espeland MA, Gaussoin SA, Bahnson J, Vaughan EM, Knowler WC, Simpson FR, et al. Impact of an 8-Year Intensive Lifestyle Intervention on an Index of Multimorbidity. J Am Geriatr Soc. 2020 Oct;68(10):2249–56.
    OpenUrlPubMed
  35. 35.↵
    Espeland MA, Justice JN, Bahnson J, Evans JK, Munshi M, Hayden KM, et al. Eight-Year Changes in Multimorbidity and Frailty in Adults With Type 2 Diabetes Mellitus: Associations With Cognitive and Physical Function and Mortality. J Gerontol A Biol Sci Med Sci. 2022 Aug 12;77(8):1691–8.
    OpenUrlPubMed
  36. 36.↵
    Fortin M, Stewart M, Ngangue P, Almirall J, Bélanger M, Brown JB, et al. Scaling Up Patient-Centered Interdisciplinary Care for Multimorbidity: A Pragmatic Mixed-Methods Randomized Controlled Trial. Ann Fam Med. 2021;19(2):126–34.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020 Jan 10;18(1):5.
    OpenUrlCrossRefPubMed
  38. 38.
    Gallo JJ, Hwang S, Joo JH, Bogner HR, Morales KH, Bruce ML, et al. Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk. J Gen Intern Med. 2016 Apr;31(4):380–6.
    OpenUrlCrossRefPubMed
  39. 39.↵
    Garvey J, Connolly D, Boland F, Smith SM. OPTIMAL, an occupational therapy led self-management support programme for people with multimorbidity in primary care: a randomized controlled trial. BMC Fam Pract. 2015 May 12;16:59.
    OpenUrlCrossRefPubMed
  40. 40.
    Gausi B, Berkowitz N, Jacob N, Oni T. Treatment outcomes among adults with HIV/non-communicable disease multimorbidity attending integrated care clubs in Cape Town, South Africa. AIDS Res Ther. 2021 Oct 14;18(1):72.
    OpenUrlCrossRefPubMed
  41. 41.↵
    Gillespie P, Hobbins A, O’Toole L, Connolly D, Boland F, Smith SM. Cost-effectiveness of an occupational therapy-led self-management support programme for multimorbidity in primary care. Fam Pract. 2022 Sep 24;39(5):826–33.
    OpenUrlPubMed
  42. 42.↵
    Hien H, Berthé A, Drabo MK, Meda N, Konaté B, Tou F, et al. Prevalence and patterns of multimorbidity among the elderly in Burkina Faso: cross-sectional study. Tropical Med Int Health. 2014 Nov;19(11):1328–33.
    OpenUrl
  43. 43.↵
    Hirst JA, Ordóñez Mena JM, O’Callaghan CA, Ogburn E, Taylor CJ, Yang Y, et al. Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function. PLoS One. 2021;16(1):e0245131.
    OpenUrlPubMed
  44. 44.↵
    Huibers CJA, Sallevelt BTGM, Heij JMJO, O’Mahony D, Rodondi N, Dalleur O, et al. Hospital physicians’ and older patients’ agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting. Eur Geriatr Med. 2022 Jun;13(3):541–52.
    OpenUrlPubMed
  45. 45.↵
    Jäger C, Steinhäuser J, Freund T, Kuse S, Szecsenyi J, Wensing M. A tailored programme to implement recommendations for multimorbid patients with polypharmacy in primary care practices-process evaluation of a cluster randomized trial. Implement Sci. 2017 Mar 6;12(1):31.
    OpenUrlPubMed
  46. 46.↵
    Jäger C, Freund T, Steinhäuser J, Stock C, Krisam J, Kaufmann-Kolle P, et al. Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices-results of a cluster-randomized controlled trial. Implement Sci. 2017 Jan 13;12(1):8.
    OpenUrlPubMed
  47. 47.↵
    Jungo K, Ansorg A, Floriani C, Rozsnyai Z, Schwab N, Meier R, et al. Optimizing Prescribing in Older Adults with Multimorbidity and Polypharmacy in Primary Care: a Cluster Randomized Clinical Trial. Journal of the American Geriatrics Society. 2023;71:S122.
    OpenUrl
  48. 48.↵
    Jungo KT, Ansorg AK, Floriani C, Rozsnyai Z, Schwab N, Meier R, et al. Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial. BMJ. 2023 May 24;381:e074054.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    Kamkuemah M, Gausi B, Oni T. High prevalence of multimorbidity and non-communicable disease risk factors in South African adolescents and youth living with HIV: Implications for integrated prevention. South African Medical Journal. 2022;112(4):259–67.
    OpenUrlPubMed
  50. 50.↵
    Keetile M, Navaneetham K, Letamo G. Prevalence and correlates of multimorbidity among adults in Botswana: a cross-sectional study. Plos one. 2020;15(9):e0239334.
    OpenUrlPubMed
  51. 51.↵
    Khunti K, Highton PJ, Waheed G, Dallosso H, Redman E, Batt ME, et al. Promoting physical activity with self-management support for those with multimorbidity: a randomised controlled trial. Br J Gen Pract. 2021 Dec;71(713):e921–30.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    Köberlein-Neu J, Mennemann H, Hamacher S, Waltering I, Jaehde U, Schaffert C, et al. Interprofessional Medication Management in Patients With Multiple Morbidities. Dtsch Arztebl Int. 2016 Nov 4;113(44):741–8.
    OpenUrlCrossRefPubMed
  53. 53.↵
    Lanzeta I, Mar J, Arrospide A. Cost-utility analysis of an integrated care model for multimorbid patients based on a clinical trial. Gac Sanit. 2016;30(5):352–8.
    OpenUrlPubMed
  54. 54.↵
    Lea M, Mowé M, Molden E, Kvernrød K, Skovlund E, Mathiesen L. Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial. BMJ Open. 2020 Dec 29;10(12):e041558.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    Lear SA, Norena M, Banner D, Whitehurst DGT, Gill S, Burns J, et al. Assessment of an Interactive Digital Health-Based Self-management Program to Reduce Hospitalizations Among Patients With Multiple Chronic Diseases: A Randomized Clinical Trial. JAMA Netw Open. 2021 Dec 1;4(12):e2140591.
    OpenUrl
  56. 56.↵
    Lin EHB, Von Korff M, Peterson D, Ludman EJ, Ciechanowski P, Katon W. Population targeting and durability of multimorbidity collaborative care management. Am J Manag Care. 2014;20(11):887–95.
    OpenUrlPubMed
  57. 57.↵
    Lo YP, Chiang SL, Lin CH, Liu HC, Chiang LC. Effects of Individualized Aerobic Exercise Training on Physical Activity and Health-Related Physical Fitness among Middle-Aged and Older Adults with Multimorbidity: A Randomized Controlled Trial. Int J Environ Res Public Health. 2020 Dec 25;18(1):101.
    OpenUrlCrossRefPubMed
  58. 58.↵
    MacKinnon MJ, Picchio CA, Nomah DK, Segura AR, Selm L van, Fernández E, et al. Chronic conditions and multimorbidity among West African migrants in greater Barcelona, Spain. Frontiers in Public Health. 2023;11:1142672.
  59. 59.
    Majert J, Nazarzadeh M, Ramakrishnan R, Bidel Z, Hedgecott D, Perez-Crespillo A, et al. Efficacy of decentralised home-based antihypertensive treatment in older adults with multimorbidity and polypharmacy (ATEMPT): an open-label randomised controlled pilot trial. Lancet Healthy Longev. 2024 Mar;5(3):e172–81.
    OpenUrl
  60. 60.↵
    Matima R, Murphy K, Levitt NS, BeLue R, Oni T. A qualitative study on the experiences and perspectives of public sector patients in Cape Town in managing the workload of demands of HIV and type 2 diabetes multimorbidity. PLoS One. 2018;13(3):e0194191.
    OpenUrlCrossRefPubMed
  61. 61.↵
    Mazya AL, Garvin P, Ekdahl AW. Outpatient comprehensive geriatric assessment: effects on frailty and mortality in old people with multimorbidity and high health care utilization. Aging Clin Exp Res. 2019 Apr;31(4):519–25.
    OpenUrlPubMed
  62. 62.↵
    Mbokazi N, van Pinxteren M, Murphy K, Mair FS, May CR, Levitt NS. Ubuntu as a mediator in coping with multimorbidity treatment burden in a disadvantaged rural and urban setting in South Africa. Social Science & Medicine. 2023;334:116190.
  63. 63.↵
    McAiney C, Markle-Reid M, Ganann R, Whitmore C, Valaitis R, Urajnik DJ, et al. Implementation of the Community Assets Supporting Transitions (CAST) transitional care intervention for older adults with multimorbidity and depressive symptoms: A qualitative descriptive study. PLoS One. 2022;17(8):e0271500.
    OpenUrlPubMed
  64. 64.
    McCarthy C, Flood M, Clyne B, Smith SM, Wallace E, Boland F, et al. Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy. Int J Clin Pharm. 2023 Feb;45(1):191–200.
    OpenUrlPubMed
  65. 65.↵
    McCarthy C, Clyne B, Boland F, Moriarty F, Flood M, Wallace E, et al. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial. PLoS Med. 2022 Jan;19(1):e1003862.
    OpenUrlCrossRefPubMed
  66. 66.↵
    McCarthy C, Pericin I, Smith SM, Kiely B, Moriarty F, Wallace E, et al. Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial. Health Expect. 2022 Dec;25(6):3225–37.
    OpenUrlPubMed
  67. 67.
    Mercer SW, Fitzpatrick B, Guthrie B, Fenwick E, Grieve E, Lawson K, et al. The CARE Plus study - a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysis. BMC Med. 2016 Jun 22;14(1):88.
    OpenUrlCrossRefPubMed
  68. 68.↵
    Miklavcic JJ, Fraser KD, Ploeg J, Markle-Reid M, Fisher K, Gafni A, et al. Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial. BMC Geriatr. 2020 May 13;20(1):174.
    OpenUrlPubMed
  69. 69.↵
    Mohamed SF, Haregu TN, Uthman OA, Khayeka-Wandabwa C, Muthuri SK, Asiki G, et al. Multimorbidity from chronic conditions among adults in urban slums: the AWI-Gen Nairobi site study findings. Global heart [Internet]. 2021 [cited 2024 May 20];16(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824985/
  70. 70.↵
    Mpinganjira MG, Chirwa T, Kabudula CW, Gómez-Olivé FX, Tollman S, Francis JM. Association of alcohol use and multimorbidity among adults aged 40 years and above in rural South Africa. Scientific Reports. 2023;13(1):7807.
    OpenUrlPubMed
  71. 71.↵
    Nagl A, Witte J, Hodek JM, Greiner W. Relationship between multimorbidity and direct healthcare costs in an advanced elderly population. Results of the PRISCUS trial. Z Gerontol Geriatr. 2012 Feb;45(2):146–54.
    OpenUrlPubMed
  72. 72.↵
    Nkoka O, Munthali-Mkandawire S, Mwandira K, Nindi P, Dube A, Nyanjagha I, et al. Association between physical multimorbidity and common mental health disorders in rural and urban Malawian settings: Preliminary findings from Healthy Lives Malawi long-term conditions survey. PLOS Global Public Health. 2024;4(4):e0002955.
    OpenUrlPubMed
  73. 73.
    Odland ML, Payne C, Witham MD, Siedner MJ, Bärnighausen T, Bountogo M, et al. Epidemiology of multimorbidity in conditions of extreme poverty: a population-based study of older adults in rural Burkina Faso. BMJ Global Health. 2020;5(3):e002096.
    OpenUrlAbstract/FREE Full Text
  74. 74.↵
    Odland ML, Ismail S, Sepanlou SG, Poustchi H, Sadjadi A, Pourshams A, et al. Multimorbidity and associations with clinical outcomes in a middle-aged population in Iran: a longitudinal cohort study. BMJ Global Health. 2022;7(5):e007278.
    OpenUrlAbstract/FREE Full Text
  75. 75.↵
    Oh H, Morey BN, Shi Y, Lee S. Distress, multimorbidity, and complex multimorbidity among Chinese and Korean American older adults. PLoS One. 2024;19(1):e0297035.
    OpenUrlPubMed
  76. 76.↵
    Olanrewaju O, Trott M, Smith L, López Sánchez GF, Carmichael C, Oh H, et al. Chronic physical conditions, physical multimorbidity, and quality of life among adults aged ≥ 50 years from six low- and middle-income countries. Qual Life Res. 2023 Apr;32(4):1031–41.
    OpenUrlPubMed
  77. 77.↵
    Oni T, Youngblood E, Boulle A, McGrath N, Wilkinson RJ, Levitt NS. Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infect Dis. 2015 Dec;15(1):20.
    OpenUrlCrossRefPubMed
  78. 78.↵
    Ose D, Kamradt M, Kiel M, Freund T, Besier W, Mayer M, et al. Care management intervention to strengthen self-care of multimorbid patients with type 2 diabetes in a German primary care network: A randomized controlled trial. PLoS One. 2019;14(6):e0214056.
    OpenUrlPubMed
  79. 79.↵
    Otieno P, Asiki G, Aheto JMK, Wilunda C, Sanya RE, Wami W, et al. Cardiometabolic Multimorbidity Associated with Moderate and Severe Disabilities: Results from the Study on Global AGEing and Adult Health (SAGE) Wave 2 in Ghana and South Africa. Global heart [Internet]. 2023 [cited 2024 May 20];18(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983501/
  80. 80.↵
    Pati S, Swain S, Metsemakers J, Knottnerus JA, van den Akker M. Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India. PLoS One. 2017;12(9):e0183966.
    OpenUrlPubMed
  81. 81.↵
    Petersen I, Rathod S, Kathree T, Selohilwe O, Bhana A. Risk correlates for physical-mental multimorbidities in South Africa: a cross-sectional study. Epidemiology and psychiatric sciences. 2019;28(4):418–26.
    OpenUrl
  82. 82.↵
    Portz JD, Kutner JS, Blatchford PJ, Ritchie CS. High Symptom Burden and Low Functional Status in the Setting of Multimorbidity. J Am Geriatr Soc. 2017 Oct;65(10):2285–9.
    OpenUrlPubMed
  83. 83.
    Prenissl J, De Neve JW, Sudharsanan N, Manne-Goehler J, Mohan V, Awasthi A, et al. Patterns of multimorbidity in India: a nationally representative cross-sectional study of individuals aged 15 to 49 years. PLOS Global Public Health. 2022;2(8):e0000587.
    OpenUrlPubMed
  84. 84.↵
    Read JR, Sharpe L, Burton AL, Areán PA, Raue PJ, McDonald S, et al. Preventing depression in older people with multimorbidity: 24-month follow-up of a trial of internet-delivered cognitive behaviour therapy. Age Ageing. 2021 Nov 10;50(6):2254–8.
    OpenUrlPubMed
  85. 85.↵
    Read J, Sharpe L, Burton AL, Arean PA, Raue PJ, McDonald S, et al. A randomized controlled trial of internet-delivered cognitive behaviour therapy to prevent the development of depressive disorders in older adults with multimorbidity. J Affect Disord. 2020 Mar 1;264:464–73.
    OpenUrlPubMed
  86. 86.↵
    Riegel B, Masterson Creber R, Hill J, Chittams J, Hoke L. Effectiveness of Motivational Interviewing in Decreasing Hospital Readmission in Adults With Heart Failure and Multimorbidity. Clin Nurs Res. 2016 Aug;25(4):362–77.
    OpenUrlCrossRefPubMed
  87. 87.↵
    Roche S, De Vries E. Multimorbidity in a large district hospital: A descriptive cross-sectional study. S Afr Med J. 2017 Nov 27;107(12):1110.
    OpenUrlPubMed
  88. 88.↵
    Romano E, Ma R, Vancampfort D, Firth J, Felez-Nobrega M, Haro JM, et al. Multimorbidity and obesity in older adults from six low-and middle-income countries. Preventive Medicine. 2021;153:106816.
    OpenUrlPubMed
  89. 89.↵
    Roomaney RA, van Wyk B, Cois A, Pillay-van Wyk V. Inequity in the distribution of non-communicable disease multimorbidity in adults in South Africa: an analysis of prevalence and patterns. International journal of public health. 2022;67:1605072.
    OpenUrlPubMed
  90. 90.
    Roomaney RA, van Wyk B, Cois A, Pillay-van Wyk V. One in five South Africans are multimorbid: An analysis of the 2016 demographic and health survey. Plos one. 2022;17(5):e0269081.
    OpenUrlCrossRefPubMed
  91. 91.↵
    Roomaney RA, Van Wyk B, Cois A, Pillay van-Wyk V. Multimorbidity patterns in South Africa: A latent class analysis. Front Public Health. 2023 Jan 11;10:1082587.
    OpenUrlPubMed
  92. 92.↵
    Roomaney RA, van Wyk B, Cois A, Pillay-van Wyk V. Multimorbidity patterns in a national HIV survey of South African youth and adults. Frontiers in public health. 2022;10:862993.
    OpenUrlPubMed
  93. 93.↵
    Salari P, O’Mahony C, Henrard S, Welsing P, Bhadhuri A, Schur N, et al. Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study. PLoS One. 2022;17(4):e0265507.
    OpenUrlCrossRefPubMed
  94. 94.↵
    Sallevelt BTGM, Huibers CJA, Heij JMJO, Egberts TCG, van Puijenbroek EP, Shen Z, et al. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs Aging. 2022 Jan;39(1):59–73.
    OpenUrlPubMed
  95. 95.↵
    Salm C, Mentzel A, Sofroniou M, Metzner G, Farin E, Voigt-Radloff S, et al. Analysis of the key themes in the healthcare of older people with multimorbidity in Germany: a framework analysis as part of the LoChro trial. BMJ Open. 2023 Aug 1;13(8):e069814.
    OpenUrlAbstract/FREE Full Text
  96. 96.↵
    Singh U, Olivier S, Cuadros D, Castle A, Moosa Y, Zulu T, et al. The met and unmet health needs for HIV, hypertension, and diabetes in rural KwaZulu-Natal, South Africa: analysis of a cross-sectional multimorbidity survey. The Lancet Global Health. 2023;11(9):e1372–82.
    OpenUrl
  97. 97.
    Smith A, Gupta A, Stone J, Habberfield J, Schneider G. The efficacy of multimodal physiotherapy and usual care in chronic whiplash-associated disorders with facet-mediated pain undergoing platelet rich plasma (PRP) treatment: a series of single case experimental designs (SCEDs). European journal of physiotherapy [Internet]. 2024; Available from: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02688107/full
  98. 98.↵
    Stanton AM, Boyd RL, O’Cleirigh C, Olivier S, Dolotina B, Gunda R, et al. HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based study. Plos one. 2024;19(2):e0293963.
    OpenUrlPubMed
  99. 99.↵
    Stubbs B, Vancampfort D, Veronese N, Schofield P, Lin PY, Tseng PT, et al. Multimorbidity and perceived stress: a population-based cross-sectional study among older adults across six low-and middle-income countries. Maturitas. 2018;107:84–91.
    OpenUrlPubMed
  100. 100.↵
    Sum G, Salisbury C, Koh GCH, Atun R, Oldenburg B, McPake B, et al. Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis. Journal of global health [Internet]. 2019 [cited 2024 May 19];9(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684869/
  101. 101.↵
    Takahashi PY, Quigg SM, Croghan IT, Schroeder DR, Ebbert JO. Effect of pedometer use and goal setting on walking and functional status in overweight adults with multimorbidity: a crossover clinical trial. Clin Interv Aging. 2016;11:1099–106.
    OpenUrlPubMed
  102. 102.↵
    Tanke MAC, Feyman Y, Bernal-Delgado E, Deeny SR, Imanaka Y, Jeurissen P, et al. A challenge to all. A primer on inter-country differences of high-need, high-cost patients. PLoS One. 2019;14(6):e0217353.
    OpenUrlPubMed
  103. 103.↵
    Lee JT, Hamid F, Pati S, Atun R, Millett C. Impact of noncommunicable disease multimorbidity on healthcare utilisation and out-of-pocket expenditures in middle-income countries: cross sectional analysis. PloS one. 2015;10(7):e0127199.
    OpenUrlCrossRefPubMed
  104. 104.↵
    Teljeur C, Smith SM, Paul G, Kelly A, O’Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract. 2013 Mar;19(1):17–22.
    OpenUrlCrossRefPubMed
  105. 105.↵
    Thorn J, Man MS, Chaplin K, Bower P, Brookes S, Gaunt D, et al. Cost-effectiveness of a patient-centred approach to managing multimorbidity in primary care: a pragmatic cluster randomised controlled trial. BMJ Open. 2020 Jan 19;10(1):e030110.
    OpenUrlAbstract/FREE Full Text
  106. 106.↵
    Tomita A, Leyna GH, Kim HY, Moodley Y, Mpolya E, Mogeni P, et al. Patterns of multimorbidity and their association with hospitalisation: a population-based study of older adults in urban Tanzania. Age and Ageing. 2021;50(4):1349–60.
    OpenUrlPubMed
  107. 107.↵
    Verdoorn S, Kwint HF, Blom JW, Gussekloo J, Bouvy ML. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study). PLoS Med. 2019 May;16(5):e1002798.
    OpenUrlCrossRefPubMed
  108. 108.↵
    Wang C, Pu R, Li Z, Ji L, Li X, Ghose B, et al. Subjective health and quality of life among elderly people living with chronic multimorbidity and difficulty in activities of daily living in rural South Africa. Clinical Interventions in Aging. 2019 Jul 17;14:1285–96.
    OpenUrlPubMed
  109. 109.↵
    Waterhouse P, Van Der Wielen N, Banda PC, Channon AA. The impact of multi-morbidity on disability among older adults in South Africa: do hypertension and socio-demographic characteristics matter? Int J Equity Health. 2017 Dec;16(1):62.
    OpenUrlPubMed
  110. 110.↵
    Webel A, Prince-Paul M, Ganocy S, DiFranco E, Wellman C, Avery A, et al. Randomized clinical trial of a community navigation intervention to improve well-being in persons living with HIV and other co-morbidities. AIDS Care. 2019 May;31(5):529–35.
    OpenUrlPubMed
  111. 111.
    Weir KR, Jungo KT, Streit S. Older adults’ adherence to medications and willingness to deprescribe: A substudy of a randomized clinical trial. Br J Clin Pharmacol. 2024 Mar;90(3):905–11.
    OpenUrlPubMed
  112. 112.↵
    Widmann M, Apondi B, Musau A, Warsame AH, Isse M, Mutiso V, et al. Comorbid psychopathology and everyday functioning in a brief intervention study to reduce khat use among Somalis living in Kenya: description of baseline multimorbidity, its effects of intervention and its moderation effects on substance use. Soc Psychiatry Psychiatr Epidemiol. 2017 Nov;52(11):1425–34.
    OpenUrlPubMed
  113. 113.
    Wittink MN, Yilmaz S, Walsh P, Chapman B, Duberstein P. Customized care: an intervention to improve communication and health outcomes in multimorbidity. Contemporary clinical trials communications. 2016;4:214–21.
    OpenUrlPubMed
  114. 114.
    Wong EB, Olivier S, Gunda R, Koole O, Surujdeen A, Gareta D, et al. Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study. The Lancet Global Health. 2021;9(7):e967–76.
    OpenUrlPubMed
  115. 115.↵
    Yao Y, Guo Y, Lip GYH, mAF-App II Trial investigators. The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial. JAMA Netw Open. 2021 Dec 1;4(12):e2140071.
    OpenUrlPubMed
  116. 116.↵
    Zechmann S, Senn O, Valeri F, Essig S, Merlo C, Rosemann T, et al. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial. BMC Geriatr. 2020 Nov 16;20(1):471.
    OpenUrlCrossRefPubMed
  117. 117.↵
    Zgibor JC, Ye L, Boudreau RM, Conroy MB, Vander Bilt J, Rodgers EA, et al. Community-Based Healthy Aging Interventions for Older Adults with Arthritis and Multimorbidity. J Community Health. 2017 Apr;42(2):390–9.
    OpenUrlPubMed
  118. 118.↵
    Andersen H, Kankaanranta H, Tuomisto L, Piirila P, Sovijarvi A, Langhammer A, et al. Multimorbidity in Finnish and Swedish speaking Finns; association with daily habits and socioeconomic status – Nordic EpiLung cross-sectional study. Preventive medicine reports [Internet]. 2021;22. Available from: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02266919/full
  119. 119.↵
    Pereira CC, Pedroso CF, Batista SRR, Guimarães RA. Prevalence and factors associated with multimorbidity in adults in Brazil, according to sex: a population-based cross-sectional survey. Frontiers in Public Health. 2023;11:1193428.
    OpenUrlPubMed
  120. 120.↵
    Saoud F, AlHenaidi M, AlOtaibi H, AlEnezi A, Mohammed M, AlOtaibi F, et al. Prevalence of and factors associated with multimorbidity among adults in Kuwait. BMC Public Health. 2024 Mar 12;24(1):768.
    OpenUrlPubMed
  121. 121.↵
    MacKay-Lyons M, Billinger SA, Eng JJ, Dromerick A, Giacomantonio N, Hafer-Macko C, et al. Aerobic exercise recommendations to optimize best practices in care after stroke: AEROBICS 2019 update. Physical therapy. 2020;100(1):149–56.
    OpenUrlPubMed
  122. 122.↵
    Zou X, Zou S, Zhang R, Xue K, Guo Y, Min H, et al. Association of Lifestyle Factors with Multimorbidity Risk in China: A National Representative Study. Applied Research Quality Life. 2024 Jun;19(3):1411–35.
    OpenUrl
  123. 123.
    Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. Journal of Thoracic Disease [Internet]. 2020 Jul [cited 2024 Aug 20];12(7). Available from: https://jtd.amegroups.org/article/view/37685
  124. 124.↵
    Zhang S, Jiang Z, Zhang H, Liu Y, Qi J, Yan Y, et al. Association of cigarette smoking, smoking cessation with the risk of cardiometabolic multimorbidity in the UK Biobank. BMC Public Health. 2024 Jul 16;24(1):1910.
    OpenUrlPubMed
  125. 125.↵
    Álvarez-Gálvez J, Ortega-Martín E, Carretero-Bravo J, Pérez-Muñoz C, Suárez-Lledó V, Ramos-Fiol B. Social determinants of multimorbidity patterns: A systematic review. Frontiers in Public Health. 2023;11:1081518.
    OpenUrlPubMed
  126. 126.↵
    Osborn CY, Kripalani S, Goggins KM, Wallston KA. Financial strain is associated with medication nonadherence and worse self-rated health among cardiovascular patients. Journal of health care for the poor and underserved. 2017;28(1):499–513.
    OpenUrl
  127. 127.↵
    Marzban S, Najafi M, Agolli A, Ashrafi E. Impact of Patient Engagement on Healthcare Quality: A Scoping Review. Journal of Patient Experience. 2022 Jan;9:237437352211254.
    OpenUrl
  128. 128.↵
    Korylchuk N, Pelykh V, Nemyrovych Y, Didyk N, Martsyniak S. Challenges and Benefits of a Multidisciplinary Approach to Treatment in Clinical Medicine. Journal of Pioneering Medical Sciences. 2024;13:1–9.
    OpenUrl
  129. 129.↵
    Taberna M, Gil Moncayo F, Jané-Salas E, Antonio M, Arribas L, Vilajosana E, et al. The Multidisciplinary Team (MDT) Approach and Quality of Care. Front Oncol. 2020 Mar 20;10:85.
  130. 130.↵
    Atkin N, Vickerstaff V, Candy B. ‘Worried to death’: the assessment and management of anxiety in patients with advanced life-limiting disease, a national survey of palliative medicine physicians. BMC Palliative Care. 2017 Dec 11;16(1):69.
    OpenUrlPubMed
  131. 131.
    Carlson DM, Yarns BC. Managing medical and psychiatric multimorbidity in older patients. Ther Adv Psychopharmacol. 2023 Aug 30;13:20451253231195274.
    OpenUrlPubMed
  132. 132.↵
    Chireh B, Essien SK, Novik N. Multimorbidity, disability, and mental health conditions in a nationally representative sample of middle-aged and older Canadians. Journal of Affective Disorders Reports. 2021 Dec 1;6:100290.
    OpenUrl
  133. 133.↵
    Karat AS, McCreesh N, Baisley K, Govender I, Kallon II, Kielmann K, et al. Waiting times, patient flow, and occupancy density in South African primary health care clinics: implications for infection prevention and control. medRxiv. 2021;2021–07.
  134. 134.
    Rema V, Sikdar K. Optimizing Patient Waiting Time in the Outpatient Department of a Multi-specialty Indian Hospital: The Role of Technology Adoption and Queue-Based Monte Carlo Simulation. SN Computer Science. 2021;2(3):200.
    OpenUrl
  135. 135.
    Mitchell M, Kan L. Digital technology and the future of health systems. Health Systems & Reform. 2019;5(2):113–20.
    OpenUrlPubMed
  136. 136.
    Awad A, Trenfield SJ, Pollard TD, Ong JJ, Elbadawi M, McCoubrey LE, et al. Connected healthcare: Improving patient care using digital health technologies. Advanced Drug Delivery Reviews. 2021;178:113958.
    OpenUrlPubMed
  137. 137.↵
    Neves AL, Burgers J. Digital technologies in primary care: Implications for patient care and future research. European Journal of General Practice. 2022;28(1):203– 8.
    OpenUrlPubMed
  138. 138.↵
    Ngangue PA, Forgues C, Nguyen T, Sasseville M, Gallagher F, Loignon C, et al. Patients, caregivers and health-care professionals’ experience with an interdisciplinary intervention for people with multimorbidity in primary care: A qualitative study. Health Expectations. 2020;23(2):318–27.
    OpenUrlPubMed
  139. 139.
    Leiva-Fernández F, Prados-Torres JD, Prados-Torres A, Del-Cura-González I, Castillo-Jimena M, López-Rodríguez JA, et al. Training primary care professionals in multimorbidity management: Educational assessment of the eMULTIPAP course. Mech Ageing Dev. 2020 Dec;192:111354.
    OpenUrlPubMed
  140. 140.↵
    Michielsen L, Bischoff EW, Schermer T, Laurant M. Primary healthcare competencies needed in the management of person-centred integrated care for chronic illness and multimorbidity: Results of a scoping review. BMC Primary Care. 2023;24(1):98.
    OpenUrlPubMed
Back to top
Posted January 29, 2025.
Download PDF

Supplementary Material

Data/Code
Email
Multimorbidity Management: A scoping review of comprehensive interventions for multimorbidity outcomes
Kagiso P Seakamela, Reneilwe G Mashaba, Cairo B Ntimana, Chodziwadziwa W Kabudula, Tholene Sodi
medRxiv 2025.01.29.25321304; doi: https://doi.org/10.1101/2025.01.29.25321304
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area